Skip to main content
. Author manuscript; available in PMC: 2024 Jul 1.
Published in final edited form as: Gastroenterology. 2023 Mar 21;165(1):252–266. doi: 10.1053/j.gastro.2023.03.206

Figure 5:

Figure 5:

Colonoscopy and HSgFOBT pathology findings from adherence over the first 4 rounds

A) Per-protocol findings for screening-colonoscopy and HSgFOBT, defined as completion of screening-colonoscopy 12 months after randomization or [1] four sequential rounds of negative HSgFOBTs, or [2] participants who had a positive HSgFOBT with proper number of preceding negative and diagnostic colonoscopy after positive HSgFOBT

B) Per-protocol findings for screening-colonoscopy and individuals who completed at least 1 but no more than 3 rounds of HSgFOBTs

C) Per-protocol findings for screening-colonoscopy and individuals who completed at least 1 but no more than 3 rounds of HSgFOBTs combined with those who sequentially completed all four rounds of HSgFOBT

D) Includes all screening in the first four rounds defined as all screening-colonoscopies as well as all HSgFOBT including crossovers